Together, Boehringer Ingelheim and Roche will leverage complementary expertise and innovative LNA technology to bring novel treatment approaches to IBD patients. Source: BioSpace
A little less than two years after tying up a multi-billion deal with Sanofi, DiCE Molecules scored another collaborative deal. Source: BioSpace
Should you invest the way billionaire investors do? Source: BioSpace
The fact that Roche has separate R&D units has been the topic of second-guessing on the part of observers and analysts. Source: BioSpace
Array BioPharma announced today that it has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel anti-cancer combinations. Source: BioSpace
The round was co-led by funds managed by new investor Janus Henderson Investors. Source: BioSpace
The round was led by Bain Capital Life Sciences. Source: BioSpace
Ultragenyx CEO Emil Kakkis said the sale of the PRV will provide the company with an "important source of non-dilutive capital" that will be used to advance the company's pipeline…
Investors are salivating at the possibility of a hot merger-and-acquisition market in 2018. Source: BioSpace
The five top-selling drugs brought in a combined $48B so far this year. Source: BioSpace